SEBI vs Rajesh Exports: ₹15 Lakh Crore Revenue Fraud Claim — 7 Red Flags Every Stock Investor Must Know

On 3 June 2026, the Securities and Exchange Board of India (SEBI) issued a 109-page interim order that instantly became one of the most consequential regulatory actions in Indian market history. The allegation: that Rajesh Exports Ltd — the Bengaluru-based gold jewellery manufacturer once counted among the world's largest — may have misrepresented approximately ₹15.15 lakh crore of consolidated revenue across five financial years, FY2020-21 to FY2024-25. SEBI's interim findings suggested prima facie that as much as 97–99% of the company's reported revenue during that period could have been inflated. The regulator described the findings as "egregious and unheard of". Two things must be said upfront. First, these are interim, prima facie findings — not a final verdict. The company and its founder-chairman Rajesh Mehta deny the allegations, and the company has said it will fully cooperate with the fresh forensic audit SEBI has ordered. Second, whatever the final outcome, this case is already a masterclass in forensic warning signs. Whether you own one stock or fifty, the seven red flags below are worth learning.

Strip away the headlines, and the interim order makes four core allegations: 1. Misrepresented revenue at an extraordinary scale. Roughly ₹15.15 lakh crore of consolidated revenue over five years — about 99.8% of the company's total reported consolidated revenue in that window — was allegedly misrepresented, according to reports of the order. 2. The overseas-subsidiary mechanism. SEBI alleged that almost the entire reported revenue was attributed to overseas subsidiaries, particularly Switzerland-based Valcambi SA, whose own audited standalone financial statements showed only a fraction of those amounts. The subsidiaries' financial statements, the regulator said, were not properly placed in the public domain. 3. Blocked scrutiny. The order alleged that forensic auditors were denied access to the company's enterprise resource planning (ERP) systems and books of account, and flagged non-cooperation with the investigation — including fund flows routed through promoter-linked entities. 4. Regulatory action. SEBI restrained Rajesh Mehta from buying, selling or otherwise dealing in the company's securities until further orders, and directed a fresh forensic audit. According to media accounts, the episode began with an email from a retail shareholder in March 2024 flagging trade receivables that had stayed unpaid for over two years — a reminder that small anomalies noticed by ordinary investors can matter enormously.

In September 2026, a parallel saga reached a milestone: Canara Bank recovered its entire ₹510 crore dues from Rajesh Exports after a Debt Recovery Tribunal (DRT) ordered the company to deposit the money to stop its properties from being sold. The account had turned non-performing back in 2020. The bank fought on three fronts — DRT proceedings (admitted 2021), NCLT insolvency action, and SARFAESI recovery — and the Karnataka High Court ultimately allowed the DRT order to be executed. Canara held the first charge over around ₹400 crore of the company's Bengaluru land and properties, plus inventory and receivables valued near ₹4,000 crore in 2023. For equity investors, the lesson is blunt: lenders were fighting to get their money back from this company as early as 2020 — six years before the SEBI order. Bank recovery action is public information, and it is data.

Regulatory allegations are one side of the story. Rajesh Mehta has denied the findings outright — "It is an interim order and nothing in it is true," he told Moneycontrol — and attributed documentation gaps to the sheer volume of company data, around 400 GB, suggesting some documents were difficult to locate rather than withheld. The company has said it will fully cooperate with the fresh forensic audit and will not challenge the interim order. Until final proceedings conclude, the allegations remain exactly that: allegations, with the company's right to a full defence intact.

Here is the genuinely useful part. Forensic accountants look for patterns, not single numbers. The Rajesh Exports case illustrates seven of them — and you can apply them to any stock you own.

When nearly all of a company's consolidated revenue comes from subsidiaries whose standalone audited statements are unavailable, inconsistent, or not in the public domain, you have structural opacity. Healthy groups disclose. The investor's job is to ask why one doesn't.

Consolidated revenue should broadly tie to segment reporting, subsidiary disclosures and — over time — cash collected from customers. Persistent, large mismatches between what the parent reports and what the subsidiaries' own audited accounts show are among the most serious signals in forensic analysis.

A clean company opens its books. When forensic auditors are refused access to ERP systems and accounting records, treat it as a five-alarm fire, not a clerical dispute.

Management that stonewalls an investigation — delayed responses, missing records, "communication gaps" — is telling you something about governance culture. Good governance cooperates early and completely.

Banks have the best view of a borrower's cash reality. An account classified as non-performing in 2020, with DRT, NCLT and SARFAESI proceedings running for years, is a giant public warning that the equity story deserves scepticism.

Money that exists on the profit-and-loss statement but never arrives as operating cash flow is the classic forensic tell. Investors often compare reported profits with the cash flow statement over several years — real businesses convert profits to cash; fictitious ones struggle to.

By the time interim orders land, share prices have usually been falling for months. A stock sliding persistently while reported numbers look strong is the market telling you it doesn't believe the numbers. Price is not proof — but sustained divergence between reported performance and market price deserves investigation, not dismissal.

An interim — often ex-parte — order is SEBI's emergency brake. Acting on prima facie evidence, the regulator restrains certain conduct while the investigation continues. It is not a finding of guilt, and the affected parties can contest it, including before the Securities Appellate Tribunal. For investors, the practical reading is this: the regulator saw enough to act immediately, and the final picture will take months or years to emerge. Don't treat interim action as a final verdict in either direction.

This is education, not advice — but these are the steps informed investors commonly take when a holding faces serious allegations: - Read the auditor's report: qualifications, emphasis-of-matter paragraphs and any auditor resignations sit in plain sight in the annual report. - Check the cash flow statement against reported profits for the last 3–5 years. - Look at promoter shareholding trends, pledging and related-party transactions in BSE/NSE filings. - Track what lenders and credit rating agencies are doing — their actions are public. - Keep position sizes modest: no single stock should be able to damage your financial plan. Diversification remains the most reliable risk control available to retail investors. - Before buying, selling or holding on such news, consult a SEBI-registered investment adviser for guidance suited to your situation.

This article is for educational purposes only and is not financial advice. Please consult a SEBI-registered investment adviser for personalized guidance. Investments are subject to market risk.